Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 12, 2026

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

An algorithm for classifying tumors based on genomic aberrations and selecting representative tumor models.

Xin Lu1, Ke Zhang, Charles Van Sant

  • 1Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Building AP-10, Dep. R4CD, Abbott Park, IL 60064, USA. xin.x.lu@abbott.com

BMC Medical Genomics
|June 24, 2010
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glecaprevir/Pibrentasvir for Acute Hepatitis C Virus Infection in Individuals with a History of Prior Hepatitis C Infection.

Infectious diseases and therapy·2026
Same author

Loss of Brain-Derived Estrogen Is Associated With Sex- and Age-Dependent Alterations in Memory, Affective Behavior, and Hippocampal Extracellular Matrix Gene Expression.

Aging cell·2026
Same author

Efficacy and Safety of Glecaprevir/Pibrentasvir in Participants with Chronic HCV Infection and Comorbidities or Multiple Concomitant Medications: An Integrated Analysis.

Infectious diseases and therapy·2026
Same author

A single-arm phase IIIb study of 8-week glecaprevir/pibrentasvir treatment in adults with acute hepatitis C.

Journal of hepatology·2025
Same author

Estrogen receptor-α ablation reverses muscle fibrosis and inguinal hernias.

The Journal of clinical investigation·2025
Same author

Updated Results from the Retrospective CREST Study on the Safety and Effectiveness of 8-Week Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated Cirrhosis.

Advances in therapy·2024

A new algorithm classifies cancer subtypes using genome-wide copy number patterns, improving tumor subgroup identification and drug development. This genomic classification predicts patient outcomes for lung, colorectal, and melanoma cancers.

Area of Science:

  • Genomics
  • Cancer Biology
  • Bioinformatics

Background:

  • Cancer is a complex disease driven by genomic aberrations, with significant variability in outcomes and treatment responses.
  • Current cancer subtyping based on individual genes is insufficient for predicting treatment efficacy.
  • Genome-wide copy number patterns offer a more comprehensive approach to cancer classification.

Purpose of the Study:

  • To develop an unsupervised classification algorithm for identifying tumor genomic subgroups based on genome-wide copy number abnormalities.
  • To create a more accurate cancer taxonomy for improved prediction of clinical outcomes and treatment responses.
  • To identify representative cell lines for each genomic subtype to facilitate drug development.

Main Methods:

  • Developed a modified genomic Non-negative Matrix Factorization (gNMF) algorithm with hierarchical clustering, random initiation, and cross-validation.

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Related Experiment Videos

Last Updated: Jun 12, 2026

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

  • Applied the algorithm to high-density SNP array data from non-small cell lung carcinoma (NSCLC), colorectal cancer (CRC), and malignant melanoma.
  • Compared the algorithm's performance against traditional clustering methods.

    • Main Results:

    • Successfully identified distinct genomic subgroups for NSCLC, CRC, and melanoma.
    • The developed algorithm outperformed traditional clustering methods in performance.
    • Genomic subtypes of NSCLC showed significant differences in overall survival and time to recurrence.
    • Identified cell lines representative of each genomic subtype.

    Conclusions:

    • Developed and validated a superior algorithm for cancer classification using genome-wide copy number aberrations.
    • The algorithm enables precise definition of cancer genomic subgroups and identification of representative cell lines.
    • This classification facilitates the assembly of cell line panels for drug candidate testing.